At the end of Q2 2025, 22 institutions reported holding Biomotion Sciences-CW29 (SLXNW) in their 13F filings, down 3 from Q1 2025. 0 opened new positions and 3 sold out. The largest holders were Polar Asset Management Partners Inc. ($30K), Linden Advisors LP ($14K) and Aristeia Capital, L.L.C. ($10K).
Company
Biomotion Sciences-CW29
Filed as
SILEXION THERAPEUTICS CORP (Q2 2025)
CUSIP
G1281K114
Latest filing quarter
Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
Institutions
Total Value
New Positions
0
$0
Exits
3
$14K
All 13F filers, Q1 2025 → Q2 2025: 177,257 shares bought and 177,570 shares sold, net −313 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.